Clinical studies have demonstrated that upregulation of ICAM‐1 in the TME is associated with a good prognosis for patients with various cancers, suggesting enhanced immune surveillance of cancer.128, 129, 130, 131. This evidence concerns the gene ICAM1 and cancer.